Blueprint Medicines shares owned by UBS Group
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $13M | 142k | 92.24 |
| 2023-09-30 | $4.0M | 80k | 50.22 |
| 2023-06-30 | $6.1M | 97k | 63.20 |
| 2023-03-31 | $4.5M | 100k | 44.99 |
| 2022-12-31 | $5.9M | 135k | 43.81 |
| 2022-09-30 | $617k | 9.4k | 65.60 |
| 2022-06-30 | $1.7M | 33k | 50.52 |
| 2022-03-31 | $3.1M | 48k | 63.83 |
| 2021-12-31 | $6.9M | 64k | 107.10 |
| 2021-09-30 | $5.4M | 53k | 102.80 |
| 2021-06-30 | $1.8M | 21k | 87.96 |
| 2021-03-31 | $6.3M | 65k | 97.23 |
| 2020-12-31 | $2.0M | 18k | 112.24 |
| 2020-09-30 | $510k | 5.5k | 92.74 |
| 2020-06-30 | $683k | 8.8k | 78.06 |
| 2020-03-31 | $238k | 4.1k | 58.53 |
| 2019-12-31 | $2.0M | 24k | 80.22 |
| 2019-09-30 | $4.4M | 60k | 73.47 |
| 2019-06-30 | $53k | 560 | 94.64 |
| 2019-03-31 | $27k | 335 | 80.60 |
| 2018-12-31 | $1.9M | 34k | 55.15 |
| 2018-09-30 | $1.8M | 23k | 77.27 |
| 2018-06-30 | $7.2M | 112k | 64.10 |
| 2018-03-31 | $5.1M | 57k | 89.84 |
| 2017-12-31 | $1.3M | 17k | 75.60 |
| 2017-09-30 | $2.3M | 33k | 69.69 |
| 2017-06-30 | $1.2M | 23k | 50.69 |
| 2017-03-31 | $293k | 7.3k | 39.98 |
| 2016-12-31 | $360k | 13k | 28.07 |
| 2016-09-30 | $98k | 3.3k | 29.50 |
| 2016-06-30 | $58k | 2.9k | 20.00 |
| 2016-03-31 | $157k | 8.8k | 17.78 |
| 2015-12-31 | $223k | 8.5k | 26.29 |
| 2015-09-30 | $179k | 8.4k | 21.47 |